SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 144 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $443,059 | +5.9% | 3,655 | 0.0% | 0.01% | +12.5% |
| Q2 2023 | $418,571 | -16.8% | 3,655 | +0.1% | 0.01% | -27.3% |
| Q1 2023 | $503,080 | +6.4% | 3,650 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $472,967 | +9.5% | 3,650 | -6.4% | 0.01% | +10.0% |
| Q3 2022 | $432,000 | +44.5% | 3,900 | -2.1% | 0.01% | +66.7% |
| Q2 2022 | $299,000 | -4.2% | 3,984 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $312,000 | -13.3% | 3,984 | -0.4% | 0.01% | 0.0% |
| Q4 2021 | $360,000 | -1.9% | 3,999 | +0.7% | 0.01% | -14.3% |
| Q3 2021 | $367,000 | +16.1% | 3,972 | -2.2% | 0.01% | +16.7% |
| Q2 2021 | $316,000 | -52.1% | 4,062 | -54.2% | 0.01% | -53.8% |
| Q1 2021 | $660,000 | -55.0% | 8,864 | +3.0% | 0.01% | -58.1% |
| Q4 2020 | $1,467,000 | +25.7% | 8,604 | +3.5% | 0.03% | +6.9% |
| Q3 2020 | $1,167,000 | -13.3% | 8,310 | -1.0% | 0.03% | -17.1% |
| Q2 2020 | $1,346,000 | +88.5% | 8,394 | +14.9% | 0.04% | +59.1% |
| Q1 2020 | $714,000 | -20.9% | 7,307 | +4.4% | 0.02% | 0.0% |
| Q4 2019 | $903,000 | +67.8% | 6,998 | -2.0% | 0.02% | +46.7% |
| Q3 2019 | $538,000 | -59.2% | 7,140 | -17.8% | 0.02% | -58.3% |
| Q2 2019 | $1,319,000 | +16.5% | 8,683 | -8.6% | 0.04% | +20.0% |
| Q1 2019 | $1,132,000 | -4.7% | 9,498 | -12.7% | 0.03% | -18.9% |
| Q4 2018 | $1,188,000 | -50.9% | 10,881 | -27.4% | 0.04% | -40.3% |
| Q3 2018 | $2,422,000 | +18.1% | 14,996 | -3.3% | 0.06% | +10.7% |
| Q2 2018 | $2,050,000 | +31.2% | 15,507 | -26.5% | 0.06% | +40.0% |
| Q1 2018 | $1,563,000 | -14.4% | 21,100 | -35.7% | 0.04% | -14.9% |
| Q4 2017 | $1,826,000 | +19.8% | 32,830 | -2.3% | 0.05% | +14.6% |
| Q3 2017 | $1,524,000 | +105.9% | 33,592 | +53.0% | 0.04% | +105.0% |
| Q2 2017 | $740,000 | +9.8% | 21,953 | -3.6% | 0.02% | +5.3% |
| Q1 2017 | $674,000 | +66.4% | 22,772 | +244.9% | 0.02% | +58.3% |
| Q3 2016 | $405,000 | +5.2% | 6,602 | -67.3% | 0.01% | +9.1% |
| Q2 2016 | $385,000 | +13.6% | 20,213 | +130.2% | 0.01% | +10.0% |
| Q4 2015 | $339,000 | +17.3% | 8,779 | -2.2% | 0.01% | +11.1% |
| Q3 2015 | $289,000 | -6.5% | 8,979 | -11.7% | 0.01% | 0.0% |
| Q2 2015 | $309,000 | -51.9% | 10,172 | -79.0% | 0.01% | -47.1% |
| Q1 2015 | $642,000 | +31.8% | 48,340 | +43.4% | 0.02% | +21.4% |
| Q4 2014 | $487,000 | +104.6% | 33,700 | +198.9% | 0.01% | +100.0% |
| Q3 2014 | $238,000 | -37.5% | 11,275 | +12.5% | 0.01% | -53.3% |
| Q2 2013 | $381,000 | – | 10,019 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |